31 July 2019: Alzheimer Europe’ adds new trials to its Clinical Trials Watch resource
Alzheimer Europe continues to develop and improve its Clinical Trials Watch (CTW), an innovative online resource providing up-to-date accessible information on clinical trials currently recruiting participants in a least one European country. The service, launched in September 2016, provides information on Phase II and III clinical trials that are investigating drugs for the prevention and treatment of dementia and/or Alzheimer’s disease.
In July 2019, Alzheimer Europe added three clinical trials to the database, which now counts eight Phase II and eleven Phase III clinical trials. The three newly-added trials are:
- LAURIET study (Phase II, Genentech)
- NorAD (Phase III, Imperial College London)
- Brexpiprazole study (Phase III, Otsuka)
Further information about the CTW is available, here.
